By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Welichem Biotech Inc. 

316-4475 Wayburne Drive

Burnaby  British Columbia  V5G 3L1  Canada
Phone: 604-432-1703 Fax: 604-432-1704


SEARCH JOBS


Industry
Biotechnology






Company News
Welichem Biotech Inc. (WBI.V) Ends Effort To Re-Acquire China Rights To Psoriasis Treatment 7/28/2014 8:03:28 AM
Welichem Biotech Inc. (WBI.V) Responds To Filing Of Take-Over Bid Circular 4/17/2014 12:21:30 PM
Welichem Biotech Inc. (WBI.V) Announces Substantial Issuer Bid 10/10/2013 9:33:27 AM
Welichem Biotech Inc. (WBI.V) Announces Substantial Issuer Bid 9/3/2013 7:35:05 AM
Welichem Biotech Inc. (WBI.V) Enters $9.8 Million Pact in China, Taiwan, Macao and Hong Kong 3/29/2013 7:04:09 AM
GlaxoSmithKline (GSK)'s Stiefel Laboratories Pays Welichem Biotech Inc. (WBI.V) $50 Million for Topical Agent for Psoriasis, Atopic Dermatitis 5/31/2012 7:29:41 AM
Welichem Biotech Inc. (WBI.V) Announces IND-Enabling Toxicology Studies for its Lead Drug, WBI-1001 4/20/2009 11:30:08 AM
Welichem Biotech Inc. (WBI.V) Announces Appointment of President & CEO 6/30/2008 7:08:58 AM
Welichem Biotech Inc. (WBI.V) Completes Phase IIa Clinical Trial on Eczema 6/20/2008 12:20:11 PM
Welichem Biotech Inc. (WBI.V) Successfully Moves to Higher Dose for Phase I Clinical Trials 9/10/2007 3:03:38 PM
12
//-->